Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Appointed director

Poseida Therapeutics, Inc. (PSTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Collins Cynthia (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
06/16/2023 4 Schmid John P. (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
06/16/2023 4 Lloyd Marcea Bland (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
06/16/2023 4 BAUM CHARLES M (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
06/16/2023 4 Corning Luke (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
05/02/2023 4 Amado Rafael (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 39,300 shares @ $0
Granted 55,200 options to buy @ $2.76, valued at $152.4k
03/02/2023 4 Warner Brent (President, Gene Therapy) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 92,772 shares @ $0
Paid exercise price by delivering 26,617 shares @ $5.35, valued at $142.4k
Granted 125,283 options to buy @ $5.35, valued at $670.3k
03/02/2023 4 Mylet Johanna (CFO) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 92,772 shares @ $0
Paid exercise price by delivering 4,323 shares @ $5.35, valued at $23.1k
Granted 125,283 options to buy @ $5.35, valued at $670.3k
03/02/2023 4 LEONHARDT HARRY J (GC & Chief Compliance Officer) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 92,772 shares @ $0
Paid exercise price by delivering 4,323 shares @ $5.35, valued at $23.1k
Granted 125,283 options to buy @ $5.35, valued at $670.3k
03/02/2023 4 Gergen Mark J (President and CEO) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 269,586 shares @ $0
Granted 364,060 options to buy @ $5.35, valued at $1.9M
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Corning Luke (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 28,500 options to buy @ $2.01, valued at $57.3k
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2022 4 Ingalls Kerry D. (COO) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Bought 3,000 shares @ $3.98, valued at $11.9k
03/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2022 4 Ingalls Kerry D. (COO) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 50,000 shares @ $0
Granted 72,568 options to buy @ $3.42, valued at $248.2k
03/01/2022 4 Mylet Johanna (CFO) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 50,000 shares @ $0
Granted 72,568 options to buy @ $3.42, valued at $248.2k
03/01/2022 4 Spear Matthew A. (Chief Medical Officer) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 50,000 shares @ $0
Granted 72,568 options to buy @ $3.42, valued at $248.2k
03/01/2022 4 Warner Brent (President, Gene Therapy) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 307,881 shares @ $0
Granted 431,034 options to buy @ $3.42, valued at $1.5M
02/01/2022 4 Gergen Mark J (President and CEO) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 357,200 shares @ $0
Granted 518,500 options to buy @ $4.75, valued at $2.5M
02/01/2022 4 Ostertag Eric (Executive Chairman) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Gifted 93,955 shares @ $0
Gifted 48,902 shares @ $0
Granted 89,500 shares @ $0
Granted 118,708 options to buy @ $4.75, valued at $563.9k
Granted 10,792 options to buy @ $0
12/22/2021 4 Mylet Johanna (CFO) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Exercised 2,616 options to buy @ $1.173, valued at $3.1k
Exercised 3,100 options to buy @ $1.933, valued at $6k
12/08/2021 4 Spear Matthew A. (Chief Medical Officer) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Exercised 10,000 options to buy @ $1.322, valued at $13.2k
12/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/29/2021 4 Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Bought 1,054 shares @ $6.8882, valued at $7.3k
Bought 27,251 shares @ $6.8068, valued at $185.5k
Bought 11,057 shares @ $6.8924, valued at $76.2k
11/23/2021 4 Malin Life Sciences Holdings Ltd (10% Owner) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Bought 11,104 shares @ $7.4433, valued at $82.7k
Bought 14,625 shares @ $6.7685, valued at $99k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy